Literature DB >> 20881430

Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study.

Christian Fynbo Christiansen1, Steffen Christensen, Dóra Körmendiné Farkas, Montserrat Miret, Henrik Toft Sørensen, Lars Pedersen.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) may have a higher risk of cardiovascular diseases (CVD) than the general population, but data are limited.
METHODS: We conducted a population-based cohort study involving Danish citizens diagnosed with MS (n = 13,963) from 1977 to 2006 and an age- and sex-matched population cohort (n = 66,407) using data on MS, arterial CVD and comorbidity from the Danish National Registry of Patients. We calculated the risk of arterial CVD for all subjects and computed adjusted incidence rate ratios (IRRs).
RESULTS: During the first year of follow-up, the risk of myocardial infarction (MI) was 0.2% among patients with MS (adjusted IRR = 1.84; 95% confidence interval, CI: 1.28-2.65, compared with population cohort members), whereas the 1-year risk of overall stroke was 0.3% (adjusted IRR = 1.96; 95% CI: 1.42-2.71). IRRs were 1.92 (95% CI: 1.27-2.90) for heart failure and 0.77 (95% CI: 0.42-1.39) for atrial fibrillation/flutter. During the subsequent 2-30 years of follow-up, IRRs remained elevated for overall stroke (1.23; 95% CI: 1.10-1.38) and heart failure (1.53; 95% CI: 1.37-1.71) but decreased for acute MI (1.10; 95% CI: 0.97-1.24).
CONCLUSION: In this Danish cohort, the risk of CVD among MS patients was low, but greater than that in the general population, particularly in the short term.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20881430     DOI: 10.1159/000320245

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  40 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

Review 2.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

3.  Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis.

Authors:  Robert W Motl; Bo Fernhall; Edward McAuley; Gary Cutter
Journal:  Neuroepidemiology       Date:  2011-05-20       Impact factor: 3.282

4.  Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.

Authors:  Raffaele Palladino; Ruth Ann Marrie; Azeem Majeed; Jeremy Chataway
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

5.  The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.

Authors:  Helen Tedeholm; Bengt Skoog; Vera Lisovskaja; Björn Runmarker; Olle Nerman; Oluf Andersen
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849

6.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

Review 7.  The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Authors:  Leah J Mische; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2018-03-17       Impact factor: 3.598

8.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

Review 9.  The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta-analysis.

Authors:  Ting Yang; Xin Tian; Chao-Yang Chen; Ling-Yun Ma; Shuang Zhou; Min Li; Ye Wu; Ying Zhou; Yi-Min Cui
Journal:  Br J Clin Pharmacol       Date:  2020-02-08       Impact factor: 4.335

Review 10.  Epidemiology and treatment of multiple sclerosis in elderly populations.

Authors:  Caila B Vaughn; Dejan Jakimovski; Katelyn S Kavak; Murali Ramanathan; Ralph H B Benedict; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.